Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISMN and Vitamin C for Hemodynamics in CKD
NCT02791906Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- May 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of isosorbide mononitrate in chronic kidney disease (CKD) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Change in Left Ventricular Mass at 24 weeks. Started May 2016; status: terminated.
02
Drugs
isosorbide mononitrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02791906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02791906.